BIIB
Biogen Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$181.55
-3.35 ▼ -1.81%
🌙 3월 13일 7:57 PM ET (한국 3/14 08:57)
$181.25
-0.30 ▼ -0.17%
| Index | S&P 500 | P/E | 20.62 | EPS (ttm) | 8.81 | Insider Own | 0.23% | Shs Outstand | 0.15B | Perf Week | -1.8% |
| Market Cap | 26.64B | Forward P/E | 11.21 | EPS next Y | 2.63% | Insider Trans | -1% | Shs Float | 0.15B | Perf Month | -5.05% |
| Enterprise Value | 29.49B | PEG | 2.68 | EPS next Q | 3.06 | Inst Own | 96.2% | Short Float | 2.87% | Perf Quarter | 2.25% |
| Income | 1.29B | P/S | 2.79 | EPS this Y | 3.23% | Inst Trans | 4.36% | Short Ratio | 2.57 | Perf Half Y | 21.98% |
| Sales | 9.53B | P/B | 1.46 | EPS next 5Y | 4.19% | ROA | 4.5% | Short Interest | 4.20M | Perf YTD | 3.16% |
| Book/sh | 124.37 | P/C | 6.98 | EPS past 3/5Y | -25.04% -18.74% | ROE | 7.39% | 52W High | -10.31% ($202.41) | Perf Year | 29.7% |
| Cash/sh | 26 | P/FCF | 12.99 | Sales past 3/5Y | 0.35% -5.06% | ROIC | 5.21% | 52W Low | 64.99% ($110.04) | Perf 3Y | -29.78% |
| Dividend Est. | - | EV/EBITDA | 9.21 | EPS Y/Y TTM | -21.29% | Gross Margin | 66.6% | Volatility(W/M) | 2.81% 2.78% | Perf 5Y | -31.78% |
| Dividend TTM | - | EV/Sales | 3.09 | Sales Y/Y TTM | 2.88% | Oper. Margin | 25.39% | ATR (14) | 5.72 | Perf 10Y | -24.12% |
| Dividend Ex-Date | - | Quick Ratio | 2.03 | EPS Q/Q | -118.25% | Profit Margin | 13.56% | RSI (14) | 43.25 | Recom | 2.28 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.68 | Sales Q/Q | -6.71% | SMA20 | -4.47% ($190.05) | Beta | 0.15 | Target Price | $209.19 |
| Payout | - | Debt/Eq | 0.36 | Earnings | 2000000 | SMA50 | -1.31% ($183.96) | Rel Volume | 0.67 | Prev Close | $184.9 |
| Employees | 7500 | LT Debt/Eq | 0.36 | EPS/Sales Surpr. | 22.45% 3.48% | SMA200 | 16.71% ($155.56) | Avg Volume(3M) | 1.64M | Price | $181.55 |
| IPO | 1991/9/17 | Option/Short | Yes/Yes | Trades | 16340 | Volume | 1,092,301 | Change | -1.81% |
뉴스 로딩 중...